Gene Knockdown Market Report

Global and Regional Gene Knockdown Market Details Research Report 2021-2026

  • POSTDATE：Jun 03, 2021
  • PAGES：163
  • REPORT CODE：GMM693518
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Gene Knockdown Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Gene Knockdown market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Gene Knockdown market.

    By Player:

    • Invitrogen (US)

    • Bio-Rad (US)

    • Sigma-Aldrich (US)

    • BioVision (US)

    • Agilent Technologies (US)

    • EMD Millipore (US)

    • MyBioSource (US)

    • Santa Cruz Biotechnology (US)

    • Abnova (Taiwan)

    • Selleck Chemicals (US)

    • Novus Biologicals (US)

    • Qiagen (Germany)

    • GeneCopoeia (US)

    • Cell Signaling Technology (US)

    • Creative Biomart (US)

    • siTOOLs Biotech (Germany)

    • OriGene (US)

    By Type:

    • siRNA

    • shRNA

    • Other

    By End-User:

    • Medical

    • Bioengineering

    • Other

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Gene Knockdown Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Gene Knockdown Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Gene Knockdown Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Gene Knockdown Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Gene Knockdown Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Gene Knockdown Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Invitrogen (US)

      • 3.1.1 Invitrogen (US) - Company Business Overview

      • 3.1.2 Invitrogen (US) - Company Financial Performance

      • 3.1.3 Invitrogen (US) - Company Financial Performance of Gene Knockdown

      • 3.1.4 Gene Knockdown Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Bio-Rad (US)

      • 3.2.1 Bio-Rad (US) - Company Business Overview

      • 3.2.2 Bio-Rad (US) - Company Financial Performance

      • 3.2.3 Bio-Rad (US) - Company Financial Performance of Gene Knockdown

      • 3.2.4 Gene Knockdown Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Sigma-Aldrich (US)

      • 3.3.1 Sigma-Aldrich (US) - Company Business Overview

      • 3.3.2 Sigma-Aldrich (US) - Company Financial Performance

      • 3.3.3 Sigma-Aldrich (US) - Company Financial Performance of Gene Knockdown

      • 3.3.4 Gene Knockdown Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 BioVision (US)

      • 3.4.1 BioVision (US) - Company Business Overview

      • 3.4.2 BioVision (US) - Company Financial Performance

      • 3.4.3 BioVision (US) - Company Financial Performance of Gene Knockdown

      • 3.4.4 Gene Knockdown Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Agilent Technologies (US)

      • 3.5.1 Agilent Technologies (US) - Company Business Overview

      • 3.5.2 Agilent Technologies (US) - Company Financial Performance

      • 3.5.3 Agilent Technologies (US) - Company Financial Performance of Gene Knockdown

      • 3.5.4 Gene Knockdown Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 EMD Millipore (US)

      • 3.6.1 EMD Millipore (US) - Company Business Overview

      • 3.6.2 EMD Millipore (US) - Company Financial Performance

      • 3.6.3 EMD Millipore (US) - Company Financial Performance of Gene Knockdown

      • 3.6.4 Gene Knockdown Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 MyBioSource (US)

      • 3.7.1 MyBioSource (US) - Company Business Overview

      • 3.7.2 MyBioSource (US) - Company Financial Performance

      • 3.7.3 MyBioSource (US) - Company Financial Performance of Gene Knockdown

      • 3.7.4 Gene Knockdown Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Santa Cruz Biotechnology (US)

      • 3.8.1 Santa Cruz Biotechnology (US) - Company Business Overview

      • 3.8.2 Santa Cruz Biotechnology (US) - Company Financial Performance

      • 3.8.3 Santa Cruz Biotechnology (US) - Company Financial Performance of Gene Knockdown

      • 3.8.4 Gene Knockdown Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Abnova (Taiwan)

      • 3.9.1 Abnova (Taiwan) - Company Business Overview

      • 3.9.2 Abnova (Taiwan) - Company Financial Performance

      • 3.9.3 Abnova (Taiwan) - Company Financial Performance of Gene Knockdown

      • 3.9.4 Gene Knockdown Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Selleck Chemicals (US)

      • 3.10.1 Selleck Chemicals (US) - Company Business Overview

      • 3.10.2 Selleck Chemicals (US) - Company Financial Performance

      • 3.10.3 Selleck Chemicals (US) - Company Financial Performance of Gene Knockdown

      • 3.10.4 Gene Knockdown Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Novus Biologicals (US)

      • 3.11.1 Novus Biologicals (US) - Company Business Overview

      • 3.11.2 Novus Biologicals (US) - Company Financial Performance

      • 3.11.3 Novus Biologicals (US) - Company Financial Performance of Gene Knockdown

      • 3.11.4 Gene Knockdown Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Qiagen (Germany)

      • 3.12.1 Qiagen (Germany) - Company Business Overview

      • 3.12.2 Qiagen (Germany) - Company Financial Performance

      • 3.12.3 Qiagen (Germany) - Company Financial Performance of Gene Knockdown

      • 3.12.4 Gene Knockdown Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 GeneCopoeia (US)

      • 3.13.1 GeneCopoeia (US) - Company Business Overview

      • 3.13.2 GeneCopoeia (US) - Company Financial Performance

      • 3.13.3 GeneCopoeia (US) - Company Financial Performance of Gene Knockdown

      • 3.13.4 Gene Knockdown Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Cell Signaling Technology (US)

      • 3.14.1 Cell Signaling Technology (US) - Company Business Overview

      • 3.14.2 Cell Signaling Technology (US) - Company Financial Performance

      • 3.14.3 Cell Signaling Technology (US) - Company Financial Performance of Gene Knockdown

      • 3.14.4 Gene Knockdown Product Benchmarking

      • 3.14.5 Strategic Initiatives

    • 3.15 Creative Biomart (US)

      • 3.15.1 Creative Biomart (US) - Company Business Overview

      • 3.15.2 Creative Biomart (US) - Company Financial Performance

      • 3.15.3 Creative Biomart (US) - Company Financial Performance of Gene Knockdown

      • 3.15.4 Gene Knockdown Product Benchmarking

      • 3.15.5 Strategic Initiatives

    • 3.16 siTOOLs Biotech (Germany)

      • 3.16.1 siTOOLs Biotech (Germany) - Company Business Overview

      • 3.16.2 siTOOLs Biotech (Germany) - Company Financial Performance

      • 3.16.3 siTOOLs Biotech (Germany) - Company Financial Performance of Gene Knockdown

      • 3.16.4 Gene Knockdown Product Benchmarking

      • 3.16.5 Strategic Initiatives

    • 3.17 OriGene (US)

      • 3.17.1 OriGene (US) - Company Business Overview

      • 3.17.2 OriGene (US) - Company Financial Performance

      • 3.17.3 OriGene (US) - Company Financial Performance of Gene Knockdown

      • 3.17.4 Gene Knockdown Product Benchmarking

      • 3.17.5 Strategic Initiatives

    4 Global Gene Knockdown Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Gene Knockdown Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of siRNA 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of shRNA 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Other 2016-2021

    • 4.3 Global Gene Knockdown Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of siRNA 2016-2021

      • 4.3.2 Global Sales and Growth Rate of shRNA 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Other 2016-2021

    • 4.4 Global Gene Knockdown Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Gene Knockdown Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Gene Knockdown Market Price By Type from 2016 to 2026

    5 Global Gene Knockdown Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Gene Knockdown

    • 5.2 Global Gene Knockdown Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Medical 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Bioengineering 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Other 2016-2021

    • 5.3 Global Gene Knockdown Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Medical 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Bioengineering 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Other 2016-2021

    • 5.4 Global Gene Knockdown Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Gene Knockdown Market Sales and Market Share by Application (Forecast)

    6 Global Gene Knockdown Market Segment Analysis (Geography Level)

    • 6.1 Global Gene Knockdown Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Gene Knockdown Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Gene Knockdown Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Gene Knockdown Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Gene Knockdown Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Gene Knockdown Market from 2016 to 2020

    7. North America Gene Knockdown Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Gene Knockdown Market Segment by Countries

      • 7.1.1 North America Gene Knockdown Market Revenue Segment by Countries

      • 7.1.2 North America Gene Knockdown Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Gene Knockdown Market Segment (Product Type Level)

    • 7.3 North America Gene Knockdown Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Gene Knockdown Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Gene Knockdown Market Segment by Countries

      • 8.1.1 Europe Gene Knockdown Market Revenue Segment by Countries

      • 8.1.2 Europe Gene Knockdown Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Gene Knockdown Market Segment (Product Type Level)

    • 8.3 Europe Gene Knockdown Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Gene Knockdown Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Gene Knockdown Market Segment by Countries

      • 9.1.1 Asia Gene Knockdown Market Revenue Segment by Countries

      • 9.1.2 Asia Gene Knockdown Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Gene Knockdown Market Segment (Product Type Level)

    • 9.3 Asia Gene Knockdown Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Gene Knockdown Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Gene Knockdown Market Segment by Countries

      • 10.1.1 South America Gene Knockdown Market Revenue Segment by Countries

      • 10.1.2 South America Gene Knockdown Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Gene Knockdown Market Segment (Product Type Level)

    • 10.3 South America Gene Knockdown Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Gene Knockdown Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Gene Knockdown Market Segment by Countries

      • 11.1.1 Middle East Gene Knockdown Market Revenue Segment by Countries

      • 11.1.2 Middle East Gene Knockdown Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Gene Knockdown Market Segment (Product Type Level)

    • 11.3 Middle East Gene Knockdown Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Gene Knockdown Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Gene Knockdown Market Segment by Countries

      • 12.1.1 Africa Gene Knockdown Market Revenue Segment by Countries

      • 12.1.2 Africa Gene Knockdown Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Gene Knockdown Market Segment (Product Type Level)

    • 12.3 Africa Gene Knockdown Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Gene Knockdown Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Gene Knockdown Market Segment by Countries

      • 13.1.1 Oceania Gene Knockdown Market Revenue Segment by Countries

      • 13.1.2 Oceania Gene Knockdown Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Gene Knockdown Market Segment (Product Type Level)

    • 13.3 Oceania Gene Knockdown Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Gene Knockdown Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Gene Knockdown

      • 14.2.2 Manufacturing Process Analysis of Gene Knockdown

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Gene Knockdown Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Gene Knockdown Industry Market Status, Pre-COVID-19

      • 15.5.3 Gene Knockdown Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Gene Knockdown Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Gene Knockdown Product Picture

    • Table Gene Knockdown Product Definition

    • Table Study Scope by Types

    • Figure Global Gene Knockdown Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Gene Knockdown Market Value by Application (2016 - 2026)

    • Figure Global Gene Knockdown Market Size and Growth Rate from 2016 to 2026

    • Table Global Gene Knockdown Production Capacity by Manufacturers (2016-2021)

    • Table Global Gene Knockdown Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Gene Knockdown Revenue by Manufacturers (2016-2021)

    • Table Global Gene Knockdown Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Gene Knockdown Plant Distribution and Sales Country

    • Table Invitrogen (US) - Company Business Overview

    • Figure Invitrogen (US) Total Revenue from 2018 to 2020

    • Table Invitrogen (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Invitrogen (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Invitrogen (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Bio-Rad (US) - Company Business Overview

    • Figure Bio-Rad (US) Total Revenue from 2018 to 2020

    • Table Bio-Rad (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bio-Rad (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Bio-Rad (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Sigma-Aldrich (US) - Company Business Overview

    • Figure Sigma-Aldrich (US) Total Revenue from 2018 to 2020

    • Table Sigma-Aldrich (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sigma-Aldrich (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Sigma-Aldrich (US)

    • Table Gene Knockdown Product Benchmarking

    • Table BioVision (US) - Company Business Overview

    • Figure BioVision (US) Total Revenue from 2018 to 2020

    • Table BioVision (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure BioVision (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of BioVision (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Agilent Technologies (US) - Company Business Overview

    • Figure Agilent Technologies (US) Total Revenue from 2018 to 2020

    • Table Agilent Technologies (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Agilent Technologies (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Agilent Technologies (US)

    • Table Gene Knockdown Product Benchmarking

    • Table EMD Millipore (US) - Company Business Overview

    • Figure EMD Millipore (US) Total Revenue from 2018 to 2020

    • Table EMD Millipore (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure EMD Millipore (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of EMD Millipore (US)

    • Table Gene Knockdown Product Benchmarking

    • Table MyBioSource (US) - Company Business Overview

    • Figure MyBioSource (US) Total Revenue from 2018 to 2020

    • Table MyBioSource (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure MyBioSource (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of MyBioSource (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Santa Cruz Biotechnology (US) - Company Business Overview

    • Figure Santa Cruz Biotechnology (US) Total Revenue from 2018 to 2020

    • Table Santa Cruz Biotechnology (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Santa Cruz Biotechnology (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Santa Cruz Biotechnology (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Abnova (Taiwan) - Company Business Overview

    • Figure Abnova (Taiwan) Total Revenue from 2018 to 2020

    • Table Abnova (Taiwan) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Abnova (Taiwan) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Abnova (Taiwan)

    • Table Gene Knockdown Product Benchmarking

    • Table Selleck Chemicals (US) - Company Business Overview

    • Figure Selleck Chemicals (US) Total Revenue from 2018 to 2020

    • Table Selleck Chemicals (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Selleck Chemicals (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Selleck Chemicals (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Novus Biologicals (US) - Company Business Overview

    • Figure Novus Biologicals (US) Total Revenue from 2018 to 2020

    • Table Novus Biologicals (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novus Biologicals (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Novus Biologicals (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Qiagen (Germany) - Company Business Overview

    • Figure Qiagen (Germany) Total Revenue from 2018 to 2020

    • Table Qiagen (Germany) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Qiagen (Germany) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Qiagen (Germany)

    • Table Gene Knockdown Product Benchmarking

    • Table GeneCopoeia (US) - Company Business Overview

    • Figure GeneCopoeia (US) Total Revenue from 2018 to 2020

    • Table GeneCopoeia (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GeneCopoeia (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of GeneCopoeia (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Cell Signaling Technology (US) - Company Business Overview

    • Figure Cell Signaling Technology (US) Total Revenue from 2018 to 2020

    • Table Cell Signaling Technology (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Cell Signaling Technology (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Cell Signaling Technology (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Creative Biomart (US) - Company Business Overview

    • Figure Creative Biomart (US) Total Revenue from 2018 to 2020

    • Table Creative Biomart (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Creative Biomart (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of Creative Biomart (US)

    • Table Gene Knockdown Product Benchmarking

    • Table siTOOLs Biotech (Germany) - Company Business Overview

    • Figure siTOOLs Biotech (Germany) Total Revenue from 2018 to 2020

    • Table siTOOLs Biotech (Germany) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure siTOOLs Biotech (Germany) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of siTOOLs Biotech (Germany)

    • Table Gene Knockdown Product Benchmarking

    • Table OriGene (US) - Company Business Overview

    • Figure OriGene (US) Total Revenue from 2018 to 2020

    • Table OriGene (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure OriGene (US) Sales and Growth Rate Analysis of Gene Knockdown

    • Figure Revenue and Market Share Analysis of OriGene (US)

    • Table Gene Knockdown Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Gene Knockdown Market Revenue by Types (Historical)

    • Table Global Gene Knockdown Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of siRNA 2016-2021

    • Figure Global Revenue and Growth Rate of shRNA 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Gene Knockdown Market Sales by Types (Historical)

    • Table Global Gene Knockdown Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of siRNA 2016-2021

    • Figure Global Sales and Growth Rate of shRNA 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Gene Knockdown Market Revenue by Types (Forecast)

    • Table Global Gene Knockdown Market Revenue Market Share by Types (Forecast)

    • Table Global Gene Knockdown Market Sales by Types (Forecast)

    • Table Global Gene Knockdown Market Sales Market Share by Types (Forecast)

    • Figure Global Gene Knockdown Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Gene Knockdown

    • Table Global Gene Knockdown Market Revenue by Application (Historical)

    • Table Global Gene Knockdown Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Medical 2016-2021

    • Figure Global Revenue and Growth Rate of Bioengineering 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Gene Knockdown Market Sales by Application (Historical)

    • Table Global Gene Knockdown Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Medical 2016-2021

    • Figure Global Sales and Growth Rate of Bioengineering 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Gene Knockdown Market Revenue by Application (Forecast)

    • Table Global Gene Knockdown Market Revenue Market Share by Application (Forecast)

    • Table Global Gene Knockdown Market Sales by Application (Forecast)

    • Table Global Gene Knockdown Market Sales Market Share by Application (Forecast)

    • Table Global Gene Knockdown Market Revenue by Geography (Historical)

    • Table Global Gene Knockdown Market Revenue Market Share by Geography (Historical)

    • Figure Global Gene Knockdown Revenue Market Share by Geography in 2020

    • Table Global Gene Knockdown Market Sales by Geography (Historical)

    • Table Global Gene Knockdown Market Sales Market Share by Geography (Historical)

    • Figure Global Gene Knockdown Sales Market Share by Geography in 2020

    • Table Global Gene Knockdown Market Revenue by Geography (Forecast)

    • Table Global Gene Knockdown Market Revenue Market Share by Geography (Forecast)

    • Table Global Gene Knockdown Market Sales by Geography (Forecast)

    • Table Global Gene Knockdown Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Gene Knockdown Revenue by Countries from 2016 to 2026

    • Table North America Gene Knockdown Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Gene Knockdown Revenue Market Share by Major Countries in 2020

    • Table North America Gene Knockdown Sales by Countries from 2016 to 2026

    • Table North America Gene Knockdown Sales Market Share by Countries from 2016 to 2026

    • Figure North America Gene Knockdown Sales Market Share by Major Countries in 2020

    • Figure USA Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure USA Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Table North America Gene Knockdown Sales by Types from 2016 to 2026

    • Table North America Gene Knockdown Sales Market Share by Types from 2016 to 2026

    • Table North America Gene Knockdown Value by Types from 2016 to 2026

    • Table North America Gene Knockdown Value Market Share by Types from 2016 to 2026

    • Table North America Gene Knockdown Sales by Application from 2016 to 2026

    • Table North America Gene Knockdown Sales Market Share by Application from 2016 to 2026

    • Table North America Gene Knockdown Value by Application from 2016 to 2026

    • Table North America Gene Knockdown Value Market Share by Application from 2016 to 2026

    • Table Europe Gene Knockdown Revenue by Countries from 2016 to 2026

    • Table Europe Gene Knockdown Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Gene Knockdown Revenue Market Share by Major Countries in 2020

    • Table Europe Gene Knockdown Sales by Countries from 2016 to 2026

    • Table Europe Gene Knockdown Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Gene Knockdown Sales Market Share by Major Countries in 2020

    • Figure Germany Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure France Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure France Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Gene Knockdown Sales by Types from 2016 to 2026

    • Table Europe Gene Knockdown Sales Market Share by Types from 2016 to 2026

    • Table Europe Gene Knockdown Value by Types from 2016 to 2026

    • Table Europe Gene Knockdown Value Market Share by Types from 2016 to 2026

    • Table Europe Gene Knockdown Sales by Application from 2016 to 2026

    • Table Europe Gene Knockdown Sales Market Share by Application from 2016 to 2026

    • Table Europe Gene Knockdown Value by Application from 2016 to 2026

    • Table Europe Gene Knockdown Value Market Share by Application from 2016 to 2026

    • Table Asia Gene Knockdown Revenue by Countries from 2016 to 2026

    • Table Asia Gene Knockdown Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Gene Knockdown Revenue Market Share by Major Countries in 2020

    • Table Asia Gene Knockdown Sales by Countries from 2016 to 2026

    • Table Asia Gene Knockdown Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Gene Knockdown Sales Market Share by Major Countries in 2020

    • Figure China Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure China Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure India Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure India Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Gene Knockdown Sales by Types from 2016 to 2026

    • Table Asia Gene Knockdown Sales Market Share by Types from 2016 to 2026

    • Table Asia Gene Knockdown Value by Types from 2016 to 2026

    • Table Asia Gene Knockdown Value Market Share by Types from 2016 to 2026

    • Table Asia Gene Knockdown Sales by Application from 2016 to 2026

    • Table Asia Gene Knockdown Sales Market Share by Application from 2016 to 2026

    • Table Asia Gene Knockdown Value by Application from 2016 to 2026

    • Table Asia Gene Knockdown Value Market Share by Application from 2016 to 2026

    • Table South America Gene Knockdown Revenue by Countries from 2016 to 2026

    • Table South America Gene Knockdown Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Gene Knockdown Revenue Market Share by Major Countries in 2020

    • Table South America Gene Knockdown Sales by Countries from 2016 to 2026

    • Table South America Gene Knockdown Sales Market Share by Countries from 2016 to 2026

    • Figure South America Gene Knockdown Sales Market Share by Major Countries in 2020

    • Figure Brazil Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Table South America Gene Knockdown Sales by Types from 2016 to 2026

    • Table South America Gene Knockdown Sales Market Share by Types from 2016 to 2026

    • Table South America Gene Knockdown Value by Types from 2016 to 2026

    • Table South America Gene Knockdown Value Market Share by Types from 2016 to 2026

    • Table South America Gene Knockdown Sales by Application from 2016 to 2026

    • Table South America Gene Knockdown Sales Market Share by Application from 2016 to 2026

    • Table South America Gene Knockdown Value by Application from 2016 to 2026

    • Table South America Gene Knockdown Value Market Share by Application from 2016 to 2026

    • Table Middle East Gene Knockdown Revenue by Countries from 2016 to 2026

    • Table Middle East Gene Knockdown Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Gene Knockdown Revenue Market Share by Major Countries in 2020

    • Table Middle East Gene Knockdown Sales by Countries from 2016 to 2026

    • Table Middle East Gene Knockdown Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Gene Knockdown Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Gene Knockdown Sales by Types from 2016 to 2026

    • Table Middle East Gene Knockdown Sales Market Share by Types from 2016 to 2026

    • Table Middle East Gene Knockdown Value by Types from 2016 to 2026

    • Table Middle East Gene Knockdown Value Market Share by Types from 2016 to 2026

    • Table Middle East Gene Knockdown Sales by Application from 2016 to 2026

    • Table Middle East Gene Knockdown Sales Market Share by Application from 2016 to 2026

    • Table Middle East Gene Knockdown Value by Application from 2016 to 2026

    • Table Middle East Gene Knockdown Value Market Share by Application from 2016 to 2026

    • Table Africa Gene Knockdown Revenue by Countries from 2016 to 2026

    • Table Africa Gene Knockdown Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Gene Knockdown Revenue Market Share by Major Countries in 2020

    • Table Africa Gene Knockdown Sales by Countries from 2016 to 2026

    • Table Africa Gene Knockdown Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Gene Knockdown Sales Market Share by Major Countries in 2020

    • Figure Nigeria Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Gene Knockdown Sales by Types from 2016 to 2026

    • Table Africa Gene Knockdown Sales Market Share by Types from 2016 to 2026

    • Table Africa Gene Knockdown Value by Types from 2016 to 2026

    • Table Africa Gene Knockdown Value Market Share by Types from 2016 to 2026

    • Table Africa Gene Knockdown Sales by Application from 2016 to 2026

    • Table Africa Gene Knockdown Sales Market Share by Application from 2016 to 2026

    • Table Africa Gene Knockdown Value by Application from 2016 to 2026

    • Table Africa Gene Knockdown Value Market Share by Application from 2016 to 2026

    • Table Oceania Gene Knockdown Revenue by Countries from 2016 to 2026

    • Table Oceania Gene Knockdown Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Gene Knockdown Revenue Market Share by Major Countries in 2020

    • Table Oceania Gene Knockdown Sales by Countries from 2016 to 2026

    • Table Oceania Gene Knockdown Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Gene Knockdown Sales Market Share by Major Countries in 2020

    • Figure Australia Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Knockdown Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Gene Knockdown Sales by Types from 2016 to 2026

    • Table Oceania Gene Knockdown Sales Market Share by Types from 2016 to 2026

    • Table Oceania Gene Knockdown Value by Types from 2016 to 2026

    • Table Oceania Gene Knockdown Value Market Share by Types from 2016 to 2026

    • Table Oceania Gene Knockdown Sales by Application from 2016 to 2026

    • Table Oceania Gene Knockdown Sales Market Share by Application from 2016 to 2026

    • Table Oceania Gene Knockdown Value by Application from 2016 to 2026

    • Table Oceania Gene Knockdown Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Gene Knockdown

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Gene Knockdown with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US